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a  b  s  t  r  a  c  t
Arterial  stiffness  may  be  a cause  of cerebral  small  vessel  disease  and  cognitive  impairment.  We  therefore
performed  a systematic  review  and  meta-analysis  of  studies  on  the  association  between  stiffness,  cerebral
small vessel  disease  and  cognitive  impairment.  For  the  associations  between  stiffness  (i.e. carotid-femoral
pulse  wave  velocity  (cfPWV),  brachial-ankle  PWV  (baPWV),  carotid  stiffness  and  pulse  pressure)  on  the
one  hand  and  cerebral  small  vessel  disease  and  cognitive  impairment  on  the  other,  we  identified  23
(n  =  15,666/20  cross-sectional;  1 longitudinal;  2  combined  cross-sectional/longitudinal)  and  41  studies
(n =  57,671/26  cross-sectional;  11 longitudinal;  4  combined  cross-sectional/longitudinal),  respectively.
Pooled  analyses  of  cross-sectional  studies  showed  that  greater  stiffness  was  associated  with  markers





tive  impairment  could  not  be  pooled  due  to large  heterogeneity.  Some  (but  not  all)  studies  showed  an
association  between  greater  stiffness  and cognitive  impairment,  and  the strength  of this  association  was
relatively  weak.  The  present  study  supports  the  hypothesis  that greater  arterial  stiffness  is  a  contributor
to  microvascular  brain  disease.
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. Introduction
Increased arterial stiffness leads to an increased pulsatile
ressure and flow load, which can damage the microcirculation
Mitchell, 2008; O’Rourke and Safar, 2005; Tzourio et al., 2014).
he brain is more vulnerable for this increased load, because
ts microcirculation is characterized by low impedance, allow-
ng the pulsatile load to penetrate deeply into its microvascular
ed (Mitchell, 2008; O’Rourke and Safar, 2005; Tzourio et al.,
014). In the brain, microvascular damage can manifest itself as
hite matter hyperintensities (WMH), cerebral microbleeds and
acunar infarcts (Wardlaw et al., 2013b), which may  ultimately
esult in cognitive impairment, including dementia (Mitchell et al.,
011).
Currently, consistent evidence is lacking, however, to support
n association between increased arterial stiffness on the one hand
nd cerebral small vessel disease and cognitive impairment on the
ther, despite the fact that in recent years a growing number of
tudies have been done on this issue. Existing studies were done
n diverse study populations and evaluated different measures of
erebral small vessel disease, cognitive function and arterial stiff-
ess. Measures of arterial stiffness included carotid-femoral pulse
ave velocity (cfPWV), brachial-ankle PWV  (baPWV) and local dis-
ensibility measurements of the carotid artery (i.e. local carotid
tiffness). These indices reflect stiffening of different parts of the
rterial tree, and may  be differentially associated with cerebral
mall vessel disease and cognitive impairment (Safar and O’Rourke,
006). In addition, some studies used pulse pressure (PP) (i.e. the
ifference between systolic and diastolic blood pressure) as a sur-
ogate measure of arterial stiffness. PP is, however, determined by
actors other than arterial stiffness, including stroke volume and
ave reflections (Safar and O’Rourke, 2006). This may  affect the
ssociation between arterial stiffness and cerebral small vessel dis-
ase and cognitive impairment.
Three previous reviews (Pase et al., 2012; Rabkin and Jarvie,
011; Singer et al., 2014) have examined the association between
rterial stiffness and microvascular brain disease. However, these
tudies evaluated only cognitive impairment (Pase et al., 2012;
abkin and Jarvie, 2011), included a limited number of measures
f arterial stiffness and cognitive impairment (Pase et al., 2012;
abkin and Jarvie, 2011), included only studies done in healthy
ndividuals (Singer et al., 2014), did not perform a study qual-
ty assessment (Pase et al., 2012; Rabkin and Jarvie, 2011; Singer
t al., 2014) and(or) did not do a meta-analysis (Singer et al.,
014).
In view of the above, we performed a systematic review and
eta-analysis of observational studies on the association between,
n the one hand, arterial stiffness (i.e. cfPWV, baPWV, local carotid . . . . .  . . .  . .  . . .  . .  . . .  . . . . .  . .  . . . . . . .  .  . . . . . . .  . . . . . .  .  . . . .  . . . . .  .  . . .  .  .  .  . . . . . . . . . .  129
stiffness and PP) and, on the other, markers of cerebral small vessel
disease and cognitive impairment.
2. Methods
This systematic review and meta-analysis is reported in accor-
dance with the PRISMA guidelines (Moher et al., 2009) (the PRISMA
checklist is provided as Supplementary material).
2.1. Data sources
We  identified relevant studies through a search of Medline and
Embase from inception to July 18, 2014 (search terms are provided
as Supplementary material). In addition, we  identified studies by
reviewing the reference lists of all relevant articles identified.
2.2. Study selection and evaluation procedure
Two reviewers (TVS and AP) selected independently all relevant
studies based on title and abstract, retrieved selected full texts, per-
formed an eligibility assessment, assessed risk of bias and extracted
data from each eligible study (described below). Any disagreements
between the reviewers were resolved by consensus.
2.3. Eligibility criteria
Human studies were eligible if they met  the following crite-
ria: (1) cross-sectional or longitudinal in design; (2) sample size
n ≥ 150; (2) investigated an association between, on the one hand,
arterial stiffness and, on the other, markers of cerebral small vessel
disease and(or) cognitive function; and (3) measured arterial stiff-
ness by cfPWV, baPWV or local carotid arterial stiffness, and(or)
measured PP, either at the level of the brachial artery (i.e. periph-
eral PP) or carotid artery or aorta (i.e. central PP). Case-control
studies were excluded, because these studies, in general, have
a relatively low internal validity. For cerebral small vessel dis-
ease, we  selected all studies with data on any of the following
magnetic resonance imaging (MRI)-detected markers: WMH,  cere-
bral microbleeds and lacunar infarcts (Wardlaw et al., 2013b). In
addition, most silent infarcts (i.e. infarcts detected in individuals
without a history of stroke/transient ischaemic attack) and sub-
cortical infarcts (i.e. cerebral infarcts in the deep brain regions not
extending into the cortex) are lacunar (Wardlaw et al., 2013b), and
were also included. Studies that used computed tomography (CT)
to detect markers of cerebral small vessel disease were excluded,
because CT is less sensitive than MRI  (Wardlaw et al., 2013b). For
cognitive function, we  selected all studies with data on any measure
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ritten in English were included. For studies that published more
han one article based upon overlapping groups of participants,
ith the same outcome measure and study design, we  included
he study with the largest number of participants.
.4. Assessment of risk of bias
Risk of bias was evaluated with a slightly modified version of
he Newcastle Ottawa Scale (NOS) (Wells et al.) (NOS is provided
s Supplementary material). The NOS includes items on partici-
ant selection, validity of measurements, whether or not results
ere adjusted for age, systolic and(or) mean blood pressure, and
for studies on cognitive function) education, plus (for longitudinal
tudies) duration and completeness of follow-up.
.5. Data extraction
Information on the following items was extracted from each
tudy with use of a standardized form: design, sample size,
opulation characteristics, measures of arterial stiffness, cerebral
mall vessel disease and cognitive impairment, unadjusted and(or)
djusted results and variable(s) that were adjusted for in the orig-
nal analyses. Classification of cognitive domains and included
ognitive function tests are described in Table S1 (Supplementary
aterial). Additional data were requested for two studies (Kearney-
chwartz et al., 2009; Nomura et al., 2010) from corresponding
uthors; one (Nomura et al., 2010) provided the requested data.
.6. Statistical analysis
We  intended to pool results of studies that were sufficiently
omogeneous with regard to study methodology and statistical
nalysis. However, such a meta-analysis was methodologically
ossible only for the cross-sectional association between cfPWV,
aPWV and local carotid stiffness on the one hand and markers
f cerebral small vessel disease on the other. Results of studies
n PP or cognitive impairment could not be pooled due to a large
eterogeneity between studies (see below).
ig. 1. Flow diagram of selection process of eligible studies on the association between art
panel  B). aSome studies evaluated multiple stiffness indices and included both a cross-seehavioral Reviews 53 (2015) 121–130 123
For the meta-analysis, results were pooled for the association
between cfPWV, baPWV and local carotid stiffness on the one
hand and a categorical measure of cerebral small vessel disease
on the other. When more than two categories were present for
WMH,  we  used the odds ratio (OR) for the highest compared to
the lowest category. For studies that measured deep and periven-
tricular WMH  separately and did not provide a measure of total
WMH,  we  included the results for periventricular WMH  only,
because periventricular WMH  is more closely related to total WMH
(DeCarli et al., 2005). For studies that measured lobar and deep
cerebral microbleeds separately and did not provide a measure of
total microbleeds, we included the results for deep microbleeds
only, because deep microbleeds are more strongly associated with
microvascular damage (Poels et al., 2010). Pooled standardized ORs
were calculated with the use of the random-effects inverse vari-
ance method. If available, we  included the fully adjusted value for
the OR. Heterogeneity between studies was investigated with Hig-
gins I2 statistic and Cochran’s Q test. An I2 > 50% and(or) a Q test
P-value < .05 indicated statistical heterogeneity. Funnel plots were
used to evaluate potential publication bias. The meta-analysis was
performed with Cochrane Review Manager Version 5.2.
3. Results
3.1. Selection process and study characteristics
Fig. 1 shows the selection process of included studies.
Of the 23 studies included on cerebral small vessel disease
(n = 15,666; 20 cross-sectional; 1 longitudinal; 2 combined cross-
sectional/longitudinal), eight evaluated cfPWV (n = 5017), 7 baPWV
(n = 3176), 1 local carotid stiffness (n = 912) and 12 PP (n = 10,775;
8 office PP, 2 ambulatory PP, 3 central PP). Of the 41 studies on
cognitive impairment (n = 57,671; 26 cross-sectional; 11 longitudi-
nal; 4 combined cross-sectional/longitudinal), 13 evaluated cfPWV
(n = 12,578), 4 baPWV (n = 1313), 1 local carotid stiffness (n = 3714)
and 28 PP (n = 50,408; 26 office PP, 3 central PP). Markers of cerebral
small vessel disease studied were WMH  (17 studies), microbleeds
(6 studies) and infarcts (10 studies). Measures of cognitive func-
tion included dementia (8 studies) and tests of global cognitive
erial stiffness and cerebral small vessel disease (panel A) and cognitive impairment
ctional and a longitudinal data analysis.
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Fig. 2. Results of the pooled analysis of the association between arterial stiffness and white matter hyperintensities (panel A), cerebral microbleeds (panel B) and cerebral
infarcts (panel C). Odds ratios are expressed per +1SD of each stiffness index. AAll included studies had adjusted the results for age and mean or systolic blood pressure,
with  the exception of Brisset et al. (2013), Ochi et al. (2010), and Saji et al. (2011, 2012), which had not adjusted for mean or systolic blood pressure. SD, standard deviation;



















t  al. 2008; Laugesen et al., 2013; Hashimoto et al. 2008; Matsumoto et al., 2007; O
ong  et al., 2013; Mitchell et al. 2011; Nomura et al., 2010).
unction (26 studies), memory (14 studies), processing speed (13
tudies) and executive function/attention (16 studies). The studies
ere conducted in the general population, or in selected clinical
opulations (e.g. individuals with diabetes, hypertension, stroke or
lzheimer’s disease) (references and full study characteristics are
rovided as Supplementary material, Tables S2–S5).
.2. Association between arterial stiffness and cerebral small
essel disease
.2.1. CfPWV, baPWV and local carotid stiffness (Fig. 2)
Of the 15 cross-sectional studies included on the association
etween cfPWV, baPWV and local carotid stiffness on the one hand
nd markers of cerebral small vessel disease on the other, eleven
73%) showed a statistically significant association between greater
rterial stiffness and cerebral small vessel disease.The one longitudinal study (Rosano et al., 2013) (Health Ageing
nd Body Composition study; n = 303, mean follow-up duration 7
ears) showed a significant association between baseline cfPWV
nd WMH  volume in the left superior longitudinal fasciculus at al. 2010; Tsao et al. 2013; Saji et al. 2011, 2012; Poels et al., 2012; Seo et al., 2008;
follow-up (for ≥ versus < median WMH  volume in this region,
standardized OR: 1.47 (95%CI 1.10; 1.95)).
For the pooled analysis, 14 cross-sectional studies (n = 8618)
were included (no longitudinal studies), of which six had mea-
sured cfPWV, seven baPWV and one local carotid stiffness. One
cross-sectional study (n = 184) (Kearney-Schwartz et al., 2009) was
excluded from this analysis because this study did not provide suf-
ficient data. The pooled analyses showed that arterial stiffness was
statistically significantly associated with WMH  (Fig. 2, panel A),
cerebral microbleeds (panel B) and cerebral infarcts (panel C). There
was no significant statistical heterogeneity (Fig. 2). In addition,
there was no funnel plot asymmetry (see Supplementary mate-
rial, Fig. S1). When we performed the pooled analyses separately
for baPWV and cfPWV, both indices were associated with markers
of cerebral small vessel disease (ORs for +1SD cfPWV 1.39 (95%CI
1.21; 1.60) and for +1SD baPWV 1.26 (95%CI 1.08; 1.46)) (see Sup-
plementary material, Fig. S2). In addition, when we  repeated the
analysis after excluding studies with a relatively high risk of bias
(NOS score ≤ 3; two  studies), results did not materially change (data
not shown).
T.T. van Sloten et al. / Neuroscience and Biobehavioral Reviews 53 (2015) 121–130 125
Table  1
Summary of study results on the association between pulse pressure and cerebral small vessel disease.
Reference Index n Age (y) Standardized effect estimate or direction of
associationa
Adjustments
WMH  Microbleeds Infarcts Age Blood pressure
Cross-sectional studies (12 studies)
Poels et al. (2010)/Verhaaren et al. (2013)b off 3979 60  0.08* OR 1.09 x
Tsao et al. (2013) cent 1419 61  0.002 OR 0.97 x x
Liao et al. (1997) (1)c off 843 63 OR 1.32 x
Liao et al. (1997) (2)c off 728 61 OR 2.17* x
Aribisala et al. (2014) off 694 73  0.04 x
Kim et al. (2011) off 692 63 +* x x
Mitchell et al. (2011) cent 668 75  −0.02 OR 1.71* x x
Ochi et al. (2010)d off 500 67 OR 1.10 x
Kim et al. (2012) off 236 66 +* x
Naganuma et al. (2011) off 179 58 OR 1.73* x
Kwon et al. (2014) amb  169 66 + x x
Henskens et al. (2008) amb  167 52 OR 0.90 OR 0.93 OR 0.93 x x
De Leeuw et al. (2004) off 152 68 + x
Longitudinal studies (2 studies)
Verhaaren et al. (2013) off 655 62 +* x
Van Dooren et al. (2014) amb  169 53 OR 1.95 x
Studies are ordered from largest to smallest sample size.
a If available, (fully adjusted) standardized effect estimates are presented. If not, direction of association is presented.
+:  higher PP associated with higher prevalence/incidence of markers of cerebral small vessel disease.
−:  higher PP associated with lower prevalence/incidence of markers of cerebral small vessel disease.
=:  no association between PP and cerebral small vessel disease; direction of association not indicated in original manuscript.
b Studies based on an overlapping population (Rotterdam study). Poels et al. (2010) describes the association between PP and microbleeds in the total population (n = 3979).
Verhaaren et al. (2013) describes in a subsample (n = 655) the association between PP and WMH.


































d Ochi et al. (2010) also evaluated the association between office PP and WMH;  r
,  years; WMH,  white matter hyperintensities; OR, odds ratio; off, office pulse press
* P < .05.
.2.2. Pulse pressure (Table 1)
Studies on the association between PP and cerebral small ves-
el disease differed markedly with regard to the statistical analysis
erformed. For instance, studies modelled PP as a continuous and
ategorical variable and calculated standardized and unstandard-
zed effect estimates. Hence, a pooled analysis was not possible.
evertheless, 6 of the 12 (50%) cross-sectional studies included
howed a statistically significant association between higher PP
nd markers of cerebral small vessel disease. The reported stan-
ardized regression coefficients ranged from −0.02 to 0.08, and the
tandardized ORs from 0.90 to 2.17.
Of the two longitudinal studies, one (Verhaaren et al., 2013)
Rotterdam Study; n = 655, mean follow-up duration 3.5 years)
howed a statistically significant association between higher base-
ine PP and increase in WMH  over time (regression coefficient per
1 SD PP for decline in ml  WMH  volume/year: −0.04 (95%CI 0.00;
.08)). The other study (Van Dooren et al., 2014) included individ-
als with hypertension (n = 169; mean follow-up duration 2 years)
nd showed a not statistically significant association between
igher baseline ambulatory PP and progression of CMB  over time
standardized OR 1.95 (95%CI 0.95; 3.90)).
.2.3. Risk of bias and heterogeneity between studies
Risk of bias among the included studies is presented in detail in
able S6 (Supplementary material). There was a moderate risk of
ias of across the studies on cerebral small vessel disease (79% of
he studies scored ≥80% of the total points on the NOS). A lower
OS score was primarily due to the failure to adjust in the analysis
or systolic or mean blood pressure (46% of the studies). In general,
he directionality of the effects did not relate to risk of bias. Studies
hat found a significant association between greater arterial stiff-
ess and cerebral small vessel disease as compared to those studies
hich did not find such an association did not differ with regard
o the variables that they adjusted for in the analysis (i.e. 50% of
ignificant studies had adjusted for age and blood pressure versus for office PP were qualitatively similar to results for central PP.
mb, ambulatory pulse pressure; cent, central pulse pressure.
54% of the nonsignificant studies, P-value = .83). In addition, there
were no differences between significant and nonsignificant studies
with regard to sample size (mean n = 778 versus n = 521), age of the
study population (mean age: 65.5 versus 60.8 years), type of popu-
lation studied (56% and 44% of significant studies were conducted
in general healthy populations and selected clinical populations,
respectively, versus 31% and 69% of the nonsignificant studies),
and total NOS score (for cross-sectional studies, mean score: 4.1
versus 3.8 points; for longitudinal studies, mean score: 6.0 versus
4.0 points) (P-values > .07).
3.3. Association between arterial stiffness and cognitive
impairment
3.3.1. CfPWV, baPWV and local carotid stiffness (Table 2)
Studies on the association between cfPWV, baPWV and local
carotid stiffness on the one hand and cognitive impairment on the
other differed markedly with regard to the methodology used. For
instance, studies used many different tests of cognitive function
and performed different statistical analyses. Hence, a pooled anal-
ysis was  not possible. Of the 11 cross-sectional studies included on
global cognitive impairment (i.e. assessment of dementia or global
cognition test), six (55%) showed a statistically significant associa-
tion with greater arterial stiffness. In addition, memory was studied
in eight cross-sectional studies: two  found a statistically significant
negative association with greater arterial stiffness. For processing
speed, two out of seven, and for executive function/attention, one
out of seven cross-sectional studies reported a statistically signif-
icant negative association. The reported standardized regression
coefficients ranged from −0.05 to 0.20.
Of the four longitudinal studies included (mean follow-up
duration ranged from 1 to 11 years), three showed a significant
association between greater arterial stiffness and global cogni-
tive decline. Three longitudinal studies also reported data on
cognitive decline in specific domains. Only one study found a
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Table  2
Summary of study results on the association between cfPWV, baPWV and local carotid stiffness on the one hand and cognitive impairment on the other.
Reference Index n Age (y) Standardized effect estimate or direction of associationa Adjustments
Dementia Global score Memory Processing speed EF/A Age Blood pressure
Cross-sectional studies (15 studies)
Poels et al. (2007)b cfPWV 3714 72 + + +* x x
Tsao et al. (2013) cfPWV 1578 61  −0.01  0.07 x x
Zhong et al. (2013) cfPWV 1433 75 +* +* + + x
Mitchell et al. (2011) cfPWV 668 75  0.10*  −0.03  0.08 x x
Watson et al. (2011) cfPWV 552 73  0.11*  0.07  0.12* x x
Elias et al. (2009) cfPWV 409 61 = =  0.13* x x
Muller et al. (2007) cfPWV 396 60  0.01  0.02  0.01 x
Sugawara et al. (2010) baPWV 388 69 + x x
Kim et al. (2009) baPWV 370 55 =
Fujiwara et al. (2005) baPWV 352 77 +* x x
Singer et al. (2013) cfPWV 319 80  −0.05  0.20  0.05  −0.03 x x
Hanon et al. (2005) cfPWV 308 78 OR 2.63* +* x x
Scuteri et al. (2013) cfPWV 280 78 +* x
Fukuhara et al. (2006) baPWV 203 85 +* x x
Kearney-Schwartz et al. (2009) cfPWV 198 69 = =
Longitudinal studies (4 studies)
Poels et al. (2007)b cfPWV 2767 71 HR 0.91 OR 0.93c OR 1.09c OR 1.10c x x
Zeki Al Hazzouri et al.
(2013)/Watson et al. (2011)d
cfPWV 2488 74 +* + − x x
Benetos et al. (2012) cfPWV 873 88 +* x x
Waldstein et al. (2008) cfPWV 582 54 +* +* + + x x
Studies are ordered from largest to smallest sample size.
a If available, (fully adjusted) standardized effect estimates are presented. If not, direction of association is presented. Mean effect estimates are presented if multiple
results  were available for the same cognitive domain.
+:  greater arterial stiffness associated with worse cognitive function.
–:  greater arterial stiffness associated with better cognitive function.
=:  no association between arterial stiffness and cognitive function; direction of association not indicated in original manuscript.
b Poels et al. (2007) also evaluated the association between carotid stiffness and cognitive impairment; results for carotid stiffness were qualitatively similar to results for
carotid-femoral pulse wave velocity.
c Cognitive decline specified as >–1SD change of the mean difference between examinations.
d Studies based on an overlapping study population (health, ageing, and body composition study). Zeki Al Hazzouri et al. (2013) describes the association between carotid-
femoral  pulse wave velocity and global cognitive decline in the total population (n = 2488). Watson et al. (2011) describes in a subsample (n = 522) the association between




























,  years; EF/A, executive function/attention; OR, odds ratio; HR, hazard ratio; cfPWV, c
ulse  wave velocity.
* P < .05.
tatistically significant association between greater arterial stiff-
ess and decline in memory. Associations with cognitive decline
n other specific domains (i.e. processing speed and executive
unction/attention) were not statistically significant. The reported
tandardized ORs/HRs ranged from 0.91 to 1.10.
.3.2. Pulse pressure (Table 3)
In general, studies on the association between PP and cognitive
mpairment had more heterogeneous results than those on cfPWV,
aPWV and local carotid stiffness and cognitive impairment. Of the
3 cross-sectional studies included on global cognitive impairment,
our (31%) showed a statistically significant association with greater
P. In addition, memory was studied in seven cross-sectional stud-
es: four found a statistically significant negative association with
reater PP. For processing speed, two out of six, and for executive
unction/attention, two out of nine cross-sectional studies reported
 statistically significant negative association. The reported stan-
ardized regression coefficients ranged from −0.02 to 0.16. In
ontrast, three studies (Davis et al., 2003; Molander et al., 2010; van
ruchem-Visser et al., 2009) found a statistically significant associa-
ion, but in the opposite direction, i.e. between higher PP and better
global and(or) domain-specific) cognitive function (Table 3). These
tudies were done in individuals with Alzheimer’s disease (Davis
t al., 2003; van Bruchem-Visser et al., 2009) or in the oldest old
i.e. individuals ≥85 years) (Molander et al., 2010).
Of the 13 longitudinal studies on global cognitive decline (mean
uration of follow-up ranged from 1 to 14 years), three (23%)
howed a statistically significant association with greater PP. In-femoral pulse wave velocity; carotid, local carotid stiffness; baPWV, brachial-ankle
addition, three longitudinal studies also reported data on cognitive
decline in specific domains. All studies found a significant asso-
ciation with decline in executive function/attention and one with
decline in memory, but none found a statistically significant associ-
ation with processing speed. In addition, one study (Qiu et al., 2003)
found a U-shaped association between PP and cognitive decline,
whereas one study (Sabayan et al., 2012) found a statistically sig-
nificant association between higher PP and lower cognitive decline.
The latter two studies were both done in older individuals (mean
age 82 and 85 years, respectively) (Table 3). The reported standard-
ized ORs ranged from 0.85 to 1.21.
3.3.3. Risk of bias and heterogeneity between studies
There was a moderate risk of bias of across the studies on cogni-
tive impairment (62% of the studies scored ≥80% of the total points
on the NOS) (individual NOS scores are provided as Supplementary
material, Table S6). A lower NOS score was  primarily due to the fail-
ure to adjust in the analysis for systolic or mean blood pressure (52%
of the studies). Studies that found a significant association between
arterial stiffness and cognitive impairment as compared to those
studies which did not find such an association had a smaller sam-
ple size (mean n = 1190 versus n = 1737), but this difference was not
statistically significant (P-value = .49). There were no differences
between significant and nonsignificant studies with regard to the
variables that they adjusted for in the analysis (i.e. 58% of signif-
icant studies had adjusted for age, education and blood pressure
versus 39% of the nonsignificant studies), age of the study popula-
tion (mean age: 70.0 versus 71.4 years), type of population studied
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Table  3
Summary of study results on the association between pulse pressure and cognitive impairment.
Reference Index n Age (y) Standardized effect estimate or direction of associationa Adjustments
Dementia Global score Memory Processing speed EF/A Age Blood pressure
Cross-sectional studies (17 studies)
Tsivgoulis et al. (2009) off 19,836 65 OR 0.98 x
Obisesan et al. (2008) off 5408 71 +* x
Tsao et al. (2013) cent 1578 61  0.07*  0.02 x x
Robbins et al. (2005) off 1563 49 +* +* +* = x x
Mitchell et al. (2011) cent 668 75  0.11*  −0.02  0.09 x x
Davis et al. (2003) off 609 74 −* −* = −* x
Sabayan et al. (2012) off 572 85 − x
Chrysohoou et al. (2012) off 535 75 OR 1.41* x
Pase et al. (2013)b cent 493 53  0.12*  0.14*  0.16* x x
Molander et al. (2010) off 476 90 −* x
Fujiwara et al. (2005) off 352 77 +* x
Yasar et al. (2011) off 337 74 − = + + x
van Bruchem-Visser et al. (2009) off 327 77 −* x
Giang et al. (2013) off 314 63 + + + − x
Kalaitzidis et al. (2013) off 256 53 + +* x
Fukuhara et al. (2006) off 203 85 + x x
Raz et al. (2011) off 158 52 = x
Longitudinal studies (13 studies)
Peters et al. (2013) off 3337 84 +*
Freitag et al. (2006) (1)c off 2505 58 + x
Freitag et al. (2006) (2)c off 2505 77 − x
Lee et al. (2013) off 1925 73 + x x
Ogunniyi et al. (2011) off 1753 76 OR 1.21* x
Waldstein et al. (2008) off 1749 57 +* +* + +* x x
Taylor et al. (2013) off 1484 50 − x
Qiu et al. (2003) off 1270 82 U*,d x x
Benetos et al. (2012) off 873 88 = x x
Morris et al. (2001) off 634 72 OR 0.85 x
McFall et al. (2014) off 599 71 +*
Yang et al. (2011) off 594 76 OR 1.00 x
Sabayan et al. (2012) off 572 85 −* x
Yasar et al. (2011) off 337 74 + + + +* x
Studies are from largest to smallest sample size.
a If available, (fully adjusted) standardized effect estimates are presented. If not, direction of association is presented. Mean effect estimates are presented if multiple
results were available for the same cognitive domain.
+:  higher PP associated with worse cognitive function.
−:  higher PP associated with better cognitive function.
=: no association between PP and cognitive function; direction of association not indicated in original manuscript.
b Pase et al. (2013) also evaluated the association between office PP and cognitive impairment; results for office PP were qualitatively similar to results for central PP.





















d U-shaped association between PP and cognitive decline.
,  years; EF/A, executive function/attention; OR, odds ratio; off, office pulse pressur
* P < .05.
62% and 38% of significant studies were conducted in general
ealthy populations and selected clinical populations, respectively,
ersus 79% and 21% of the nonsignificant studies), total NOS score
for cross-sectional studies, mean score: 3.9 versus 3.6 points; for
ongitudinal studies, mean score: 6.0 versus 6.8 points) and, for




The present systematic review and meta-analysis had two  main
ndings. First, with regard to the systematic review, most stud-
es showed an independent association between greater arterial
tiffness, as measured by cfPWV, baPWV, local carotid stiffness
nd PP, and markers of cerebral small vessel disease. In addition,
tudies found an association between higher cfPWV, baPWV and
ocal carotid stiffness on the one hand and cognitive impairment
n the other, but the strength of this association was  relatively
eak. In addition, results on the association between PP and cog-
itive impairment were inconsistent. Second, with regard to the
eta-analysis, pooled analysis showed a statistically significantt, central pulse pressure.
and strong association between greater arterial stiffness and mark-
ers of cerebral small vessel disease.
4.2. Association between arterial stiffness and cerebral small
vessel disease
The results of the pooled analysis of cross-sectional studies
showed that higher cfPWV, baPWV and local carotid stiffness were
statistically significantly associated with markers of cerebral small
vessel disease with standardized ORs of 1.29–1.32. These results
strongly suggest that arterial stiffness is an important risk indi-
cator of microvascular disease, with a strength of the association
comparable to that of the association between arterial stiffness and
measures of atherosclerosis (e.g. ankle-brachial index and coronary
calcium score; Safar and O’Rourke, 2006).
4.3. Association between arterial stiffness and cognitive
impairmentSome studies also showed an association between higher
cfPWV, baPWV and local carotid stiffness on the one hand and
cognitive impairment on the other. Estimated effect sizes were,
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ignificant in a relatively low number of studies. This weak asso-
iation may  be due to the fact that mechanisms other than
icrovascular disease play a role in the pathobiology of cogni-
ive impairment, including neurodegenerative pathology and the
rocess of atherothrombosis.
In addition, PP was less consistently associated with cognitive
mpairment than cfPWV, baPWV and local carotid stiffness. Some
tudies showed an association between higher PP and worse cogni-
ive function, whereas other studies found an inverted association,
.e. higher PP was  associated with better cognitive function. These
tudies (Davis et al., 2003; Molander et al., 2010; Sabayan et al.,
012; van Bruchem-Visser et al., 2009) were all done in (biolog-
cally) older individuals. The presence of an inverted association
n these individuals may  have several explanations. Possibly, cog-
itive impairment or the process of neurodegeneration may  cause
ysregulation of blood pressure and, thereby, a decline in PP (Muller
t al., 2014). Alternatively, in frail older individuals low blood pres-
ure (including low PP) may, as a result of a dysfunctional vascular
ystem, comprise perfusion of the brain, which may  manifest as
ognitive impairment (Muller et al., 2014).
.4. Methodological considerations
Some methodological issues warrant consideration. First, the
ssociations found might have been overestimated due to publi-
ation bias. The funnel plot of studies on the association between
rterial stiffness and cerebral small vessel disease did not show
substantial) asymmetry (such asymmetry may  indicate the pres-
nce of publication bias). However, studies on the association
etween arterial stiffness and cognitive impairment that found a
ignificant association as compared to those studies which did not
nd such an association had a relatively smaller sample size. This
ay  indicate the presence of publication bias, and suggests that
he association between arterial stiffness and cognitive impair-
ent may  have been overestimated in earlier research. Second,
ost of the included studies were cross-sectional by design, which
recludes a conclusion about the temporality of the studied associ-
tions. Nevertheless, the few studies with a longitudinal design did
how that greater arterial stiffness was present before the presence
f cerebral small vessel disease or cognitive impairment. Third, the
resent review included observational studies and we,  therefore,
annot draw definite conclusions on causality. Fourth, a relatively
igh number of the studies did not adjust for systolic or mean
lood pressure. Blood pressure is an important confounder in the
ssociation between arterial stiffness and microvascular disease.
n those studies that did adjust for blood pressure, however, the
ssociation between arterial stiffness and cerebral small vessel dis-
ase/cognitive impairment remained. Fifth, results of studies on
P or cognitive impairment could not be pooled due to a large
eterogeneity. Sixth, due to the design of the present systematic
eview and (aggregate-data) meta-analysis, it was  not possible to
ake a direct comparison between different stiffness indices with
egard to the strength of their association with cerebral small ves-
el disease/cognitive impairment. This issue requires further study.
eventh, only a limited number of studies measured local carotid
tiffness, and ambulatory PP or central PP (almost all studies evalu-
ted brachial office PP). Evidence for an association between these
ndices and microvascular brain disease is, therefore, weak and
his issue requires further study. Finally, it is not fully clear why
ome studies found a significant association between arterial stiff-
ess and cerebral small vessel disease/cognitive impairment and
thers did not. There were no differences between significant and
onsignificant studies with regard to the populations studied (i.e.
eneral healthy populations versus selected clinical populations
nd age of the study population) and risk of bias (NOS scores).ehavioral Reviews 53 (2015) 121–130
4.5. Assumptions underlying the studied associations
Important assumptions underlying the associations evaluated
in the present review are that markers of cerebral small vessel dis-
ease are valid indicators of cerebral microvascular damage, and that
microvascular damage is involved in the pathobiology of cognitive
impairment. Previous studies (Fisher, 1979; Wardlaw et al., 2013a,
2013b; Young et al., 2008) have indeed demonstrated that markers
of cerebral small vessel disease represent both abnormal cerebral
microvascular structure and function. For instance, studies have
demonstrated that WMH,  cerebral microbleeds and lacunar infarcts
are associated with disruption and a greater permeability of the
blood-brain layer as well as arteriosclerotic changes in small arter-
ies/arterioles. In addition, previous studies (Gorelick et al., 2011;
Mitchell, 2008; Mitchell et al., 2011; Wardlaw et al., 2013b) have
shown a consistent association between cerebral small vessel dis-
ease and cognitive impairment.
4.6. Underlying mechanisms
The mechanism that may  underlie the observed associations is
that greater arterial stiffness leads to microcirculatory damage via
an increased pulsatile pressure and flow load. This increased load
may  directly cause cerebral microvascular damage, despite blood-
pressure-related protective autoregulatory mechanisms (Mitchell,
2008; O’Rourke and Safar, 2005; Tzourio et al., 2014). Alternatively,
the increased pulsatile load may  induce a microvascular remod-
elling response, which initially serves to limit the penetration of
the pressure load on the microcirculatory system by raising vascu-
lar resistance. Yet, this protective response may  ultimately become
unfavourable, leading to impaired vasoreactivity and microvascu-
lar ischaemia. It is, moreover, likely that these mechanisms operate
simultaneously.
5. Conclusion
The present systematic review and meta-analysis shows a con-
sistent association across different cross-sectional studies between
greater arterial stiffness and markers of cerebral small vessel dis-
ease. This supports the hypothesis that greater arterial stiffness
is a contributor to microvascular brain disease. The strength of
the association between greater arterial stiffness and cognitive
impairment was, however, relatively weak, and might have been
overestimated due to publication bias. Arterial stiffness may  be
a therapeutic target for the prevention of microvascular brain
disease and, possibly, cognitive impairment. However, further
well-powered longitudinal studies are warranted that investigate
the temporality of the association between arterial stiffness, cere-
bral small vessel disease and cognitive impairment.
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